BE743905A - - Google Patents
Info
- Publication number
- BE743905A BE743905A BE743905DA BE743905A BE 743905 A BE743905 A BE 743905A BE 743905D A BE743905D A BE 743905DA BE 743905 A BE743905 A BE 743905A
- Authority
- BE
- Belgium
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR182571A FR8266M (en) | 1968-12-31 | 1968-12-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE743905A true BE743905A (en) | 1970-05-28 |
Family
ID=8659685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE743905D BE743905A (en) | 1968-12-31 | 1969-12-30 |
Country Status (7)
| Country | Link |
|---|---|
| BE (1) | BE743905A (en) |
| CA (1) | CA959850A (en) |
| CH (1) | CH511248A (en) |
| DE (1) | DE1965343A1 (en) |
| ES (1) | ES375023A1 (en) |
| FR (1) | FR8266M (en) |
| GB (1) | GB1299201A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2070181A1 (en) * | 1969-10-30 | 1971-09-10 | Merck & Co Inc | |
| EP0348541A1 (en) * | 1988-06-29 | 1990-01-03 | YASON S.r.l | N-carbethoxy-4-thiazolidine-carboxylic acid, process for its preparation and its use as medicament |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2222087B1 (en) * | 1973-03-22 | 1976-04-09 | Ferlux | |
| IT1190945B (en) * | 1982-08-06 | 1988-02-24 | Salus Research Sarm Spa | COMPOUND WITH BRONCHO-SECRETOGOGUE, FLUIDIFYING AND ANTITUSSIGENIC ACTION, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT |
| DE3376341D1 (en) * | 1982-08-09 | 1988-05-26 | Ajinomoto Kk | Method for producing 2-substituted-thiazolidine-4-carboxylic acids |
| HU195492B (en) * | 1984-07-27 | 1988-05-30 | Boehringer Biochemia Srl | Process for producing 2-substituted thiazolidine derivatives with antitussive and mucus regulating action and pharmaceuticals comprising these compounds as active ingredient |
-
1968
- 1968-12-31 FR FR182571A patent/FR8266M/fr not_active Expired
-
1969
- 1969-07-30 CH CH1157869A patent/CH511248A/en not_active IP Right Cessation
- 1969-12-29 DE DE19691965343 patent/DE1965343A1/en active Pending
- 1969-12-30 BE BE743905D patent/BE743905A/xx unknown
- 1969-12-30 CA CA071,114A patent/CA959850A/en not_active Expired
- 1969-12-30 ES ES375023A patent/ES375023A1/en not_active Expired
- 1969-12-31 GB GB63488/69A patent/GB1299201A/en not_active Expired
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2070181A1 (en) * | 1969-10-30 | 1971-09-10 | Merck & Co Inc | |
| EP0348541A1 (en) * | 1988-06-29 | 1990-01-03 | YASON S.r.l | N-carbethoxy-4-thiazolidine-carboxylic acid, process for its preparation and its use as medicament |
Also Published As
| Publication number | Publication date |
|---|---|
| CA959850A (en) | 1974-12-24 |
| FR8266M (en) | 1970-10-26 |
| ES375023A1 (en) | 1972-03-01 |
| GB1299201A (en) | 1972-12-13 |
| CH511248A (en) | 1971-08-15 |
| DE1965343A1 (en) | 1970-07-23 |